Finetech Pharmaceutical Ltd.

Israel

Back to Profile

1-3 of 3 for Finetech Pharmaceutical Ltd. Sort by
Query
Aggregations
Jurisdiction
        United States 2
        World 1
Date
2024 1
2022 1
Before 2020 1
IPC Class
C07F 7/18 - Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages 2
A61K 31/165 - Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide 1
A61P 27/02 - Ophthalmic agents 1
C07C 1/34 - Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon starting from compounds containing hetero atoms other than, or in addition to, oxygen or halogen reacting phosphines with aldehydes or ketones, e.g. Wittig reaction 1
C07C 231/24 - SeparationPurification 1
See more
Status
Pending 1
Registered / In Force 2
Found results for  patents

1.

PROCESS FOR THE PREPARATION OF ERIBULIN

      
Application Number 18039815
Status Pending
Filing Date 2021-12-02
First Publication Date 2024-03-21
Owner FineTech Pharmaceutical Ltd. (Israel)
Inventor
  • Rukhman, Igor
  • Zaltsman, Igor
  • Yudovich, Lev
  • Grossman, Olga
  • Fedotev, Irina
  • Gutman, Arie

Abstract

The present invention relates to a process for the preparation of Eribulin.

IPC Classes  ?

  • C07D 493/22 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
  • C07D 405/14 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

2.

PROCESS FOR THE PREPARATION OF ERIBULIN

      
Application Number IL2021051440
Publication Number 2022/118321
Status In Force
Filing Date 2021-12-02
Publication Date 2022-06-09
Owner FINETECH PHARMACEUTICAL LTD. (Israel)
Inventor
  • Rukhman, Igor
  • Zaltsman, Igor
  • Yudovich, Lev
  • Grossman, Olga
  • Fedotev, Irina
  • Gutman, Arie

Abstract

The present invention relates to a process for the preparation of Eribulin.

IPC Classes  ?

  • C07D 315/00 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups
  • C07D 307/20 - Oxygen atoms
  • C07D 309/20 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hydrogen atoms and substituted hydrocarbon radicals directly attached to ring carbon atoms
  • C07C 1/34 - Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon starting from compounds containing hetero atoms other than, or in addition to, oxygen or halogen reacting phosphines with aldehydes or ketones, e.g. Wittig reaction
  • C07C 45/29 - Preparation of compounds having C=O groups bound only to carbon or hydrogen atomsPreparation of chelates of such compounds by oxidation of hydroxy groups
  • C07F 7/18 - Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages

3.

Bimatoprost crystalline form I

      
Application Number 11896002
Grant Number 07947740
Status In Force
Filing Date 2007-08-29
First Publication Date 2009-06-25
Grant Date 2011-05-24
Owner Finetech Pharmaceutical Ltd (Israel)
Inventor
  • Gutman, Arie
  • Rukhman, Igor
  • Tishin, Boris
  • Yudovich, Lev
  • Vilensky, Alexander
  • Pertsikov, Boris
  • Nisnevich, Gennady

Abstract

The invention provides a novel polymorphic form I of crystalline bimatoprost, method for preparation thereof and new crystalline intermediates in the preparation. This form I of crystalline bimatoprost is used in purification of crude bimatoprost and in storage of bimatoprost as active pharmaceutical intermediate. Use of the physical form of bimatoprost in the manufacture of a medicament is also disclosed.

IPC Classes  ?

  • A61K 31/165 - Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
  • C07C 235/34 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
  • C07C 231/24 - SeparationPurification
  • A61P 27/02 - Ophthalmic agents
  • C07F 7/18 - Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages